The isoquinoline alkaloid berberine inhibits human cytomegalovirus replication by interfering with the viral Immediate Early-2 (IE2) protein transactivating activity.-Reference-Cited by-同舟云学术

The isoquinoline alkaloid berberine inhibits human cytomegalovirus replication by interfering with the viral Immediate Early-2 (IE2) protein transactivating activity.

Published:2019-04 Issue: Volume:164 Page:52-60
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Luganini Anna,Mercorelli Beatrice^ORCID,Messa Lorenzo,Palù Giorgio,Gribaudo Giorgio,Loregian Arianna

Funder

AIRC

Progetto di Ricerca di Ateneo 2014

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference57 articles.

1. The phosphorylation status of the serine-rich region of the human cytomegalovirus 86-kilodalton major immediate-early protein IE2/IEP86 affects temporal viral gene expression;Barrasa;J. Virol.,2005

2. Identification of compounds with anti-human cytomegalovirus activity that inhibit production of IE2 proteins;Beelontally;Antivir. Res.,2017

3. Meeting report: 31st international conference on antiviral Research;Bray;Antivir. Res.,2018

4. The cyclin E promoter is activated by human cytomegalovirus 86-kDa immediate early protein;Bresnahan;J. Biol. Chem.,1998

5. Maternal immunity and the natural history of congenital human cytomegalovirus infection;Britt;Viruses,2018

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking the potential of Berberine: Advancing cancer therapy through chemosensitization and combination treatments;Cancer Letters;2024-08

2. Systematic Review of Chemical Compounds with Immunomodulatory Action Isolated from African Medicinal Plants;Molecules;2024-04-26

3. Biologically active isoquinoline alkaloids covering 2019–2022;Bioorganic Chemistry;2024-04

4. Human neural progenitor cell models to study the antiviral effects and neuroprotective potential of approved and investigational human cytomegalovirus inhibitors;Antiviral Research;2024-03

5. Antiviral history and viral targets for antiviral therapy;Microbial Genomics: Clinical, Pharmaceutical, and Industrial Applications;2024